Key opinion leaders explore the clinical and economic burden of dementia-related psychosis and the unmet medical need.
Primary care physician, Stephen A. Brunton, MD, considers the role of experiential training in the diagnosis and treatment of dementia-related psychosis (DRP). Then, a discussion regarding the identification and diagnosis of patients with DRP is provided. Next, Gary W. Small, MD, reviews the APA guidelines for recommending pharmacologic treatment in patients with DRP and finally, Dr Brunton discusses the delay between suspicion of DRP and initial specialist consult.
The speakers are paid consultants on behalf of Acadia Pharmaceuticals Inc. This is a disease-awareness, non-CME program sponsored by Acadia Pharmaceuticals Inc.